TNFRSF10B and non-small cell lung carcinoma: Our previous study indicated that pemetrexed (PEM), an inhibitor of folic acid synthesis used for the treatment of NSCLC patients currently10,11, can induce apoptosis by upregulating the expression of TNFRSF10B in NSCLC cells12.